12th Maggio 2022
Comunicati stampa
Scopri tutto su i nostri comunicati stampa recenti, resta aggiornato sulle ultime notizie e informati sui prossimi eventi a cui Curium parteciperà.
3rd Maggio 2022
Curium’s Phase 3 ECLIPSE Trial Starts Enrolling Patients
19th Aprile 2022
Curium Announces Significant Increase in Detectnet™ (copper Cu 64 dotatate injection) Production Capacity
5th Aprile 2022
Curium Announces FDA Approval of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
25th Gennaio 2022
Curium to become major player in the supply on non carrier added Lu-177
15th Dicembre 2021
Curium is pleased to announce that Sakir Mutevelic MD, MSc has joined as global Chief Medical Officer
27th Ottobre 2021
Curium Initiates ECLIPSE, a Phase 3 Clinical Trial For Its Investigational Lu 177 PSMA I&T
24th Agosto 2021
Curium Announces Submission of an Investigational New Drug (IND) Application for Cu-64 PSMA I&T
1st Giugno 2021
Curium Acquires Austrian Radiopharmaceuticals Company IASON
5th Maggio 2021
RadioMedix & Curium Announce Detectnet™ (copper Cu 64 dotatate injection) Inclusion on NCCN Guidelines®
4th Maggio 2021
Curium Announces Filing of a Generic Version of DaTscan™ (Ioflupane I 123 Injection) in the U.S.
28th Aprile 2021
Curium to Expand Noblesville Facility’s Workforce
23rd Marzo 2021
RadioMedix & Curium Announce Simplified Coding for Detectnet™ (copper Cu 64 dotatate injection)
2nd Marzo 2021
Eckert & Ziegler’s GalliaPharm® distributed by Curium in France
26th Gennaio 2021
RadioMedix & Curium Announce Permanent HCPCS Code for Detectnet™ (copper Cu 64 dotatate injection)
9th Dicembre 2020
RadioMedix & Curium Announce CMS Transitional Pass-Through Status for Detectnet™ (copper Cu 64 dotatate injection)
8th Settembre 2020
RadioMedix and Curium Announce FDA Approval of Detectnet (copper Cu 64 dotatate injection) in the U.S.
9th Giugno 2020
Curium Announces Drug Master File and Active Substance Master File for Germanium-68 in the U.S. and Europe
24th Marzo 2020
Curium Announces Approval of PulmotechTM MAA (kit for the preparation of technetium Tc 99m albumin aggregated injection) by the U.S. Food and Drug Administration
12th Marzo 2020